Healthcare provider profile · identity verified

Billy Back, MD

Internal Medicine · GREENWICH, OH · NPI 1831191444

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	399	94
Lisinopril	Lisinopril	341	84
Amlodipine Besylate	Amlodipine Besylate	334	84
Pantoprazole Sodium	Pantoprazole Sodium	291	75
Metoprolol Tartrate	Metoprolol Tartrate	286	63
Metformin Hcl	Metformin Hcl	283	75
Levothyroxine Sodium	Levothyroxine Sodium	238	57
Losartan Potassium	Losartan Potassium	233	57
Furosemide	Furosemide	220	59
Sertraline Hcl	Sertraline Hcl	216	45
Potassium Chloride	Potassium Chloride	213	44
Tamsulosin Hcl	Tamsulosin Hcl	178	53
Omeprazole	Omeprazole	162	42
Gabapentin	Gabapentin	145	39
Simvastatin	Simvastatin	144	42
Rosuvastatin Calcium	Rosuvastatin Calcium	141	37
Albuterol Sulfate Hfa	Albuterol Sulfate	134	34
Metoprolol Succinate	Metoprolol Succinate	130	34
Prednisone	Prednisone	127	84
Montelukast Sodium	Montelukast Sodium	126	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	121	34
Eliquis	Apixaban	114	31
Clopidogrel	Clopidogrel Bisulfate	113	27
Hydrochlorothiazide	Hydrochlorothiazide	113	25
Famotidine	Famotidine	94	28
Hydralazine Hcl	Hydralazine Hcl	93	24
Spironolactone	Spironolactone	92	25
Duloxetine Hcl	Duloxetine Hcl	90	28
Allopurinol	Allopurinol	87	19
Januvia	Sitagliptin Phosphate	86	11
Pravastatin Sodium	Pravastatin Sodium	83	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	82	23
Ropinirole Hcl	Ropinirole Hcl	81	20
Amitriptyline Hcl	Amitriptyline Hcl	78	18
Cephalexin	Cephalexin	74	61
Venlafaxine Hcl Er	Venlafaxine Hcl	68	12
Fluticasone Propionate	Fluticasone Propionate	67	19
Carvedilol	Carvedilol	64	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	11
Pioglitazone Hcl	Pioglitazone Hcl	63	15
Clonidine Hcl	Clonidine Hcl	62	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	59	16
Atenolol	Atenolol	56	14
Buspirone Hcl	Buspirone Hcl	56	20
Sucralfate	Sucralfate	55	17
Tramadol Hcl	Tramadol Hcl	54	19
Escitalopram Oxalate	Escitalopram Oxalate	53	15
Tizanidine Hcl	Tizanidine Hcl	53	24
Meloxicam	Meloxicam	48	13
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	48	48
Citalopram Hbr	Citalopram Hydrobromide	46	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	41
Farxiga	Dapagliflozin Propanediol	44	suppressed
Levofloxacin	Levofloxacin	43	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	42	34
Lovastatin	Lovastatin	42	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	15
Ondansetron Hcl	Ondansetron Hcl	40	18
Trazodone Hcl	Trazodone Hcl	40	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Azithromycin	Azithromycin	30	29
Finasteride	Finasteride	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	15
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Roflumilast	Roflumilast	30	suppressed
Klor-Con M20	Potassium Chloride	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Ozempic	Semaglutide	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Bumetanide	Bumetanide	22	suppressed
Digoxin	Digoxin	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Fluconazole	Fluconazole	18	11
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Linzess	Linaclotide	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Temazepam	Temazepam	16	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Amoxicillin	Amoxicillin	12	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Topiramate	Topiramate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nystatin	Nystatin	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error